EYE » Topics » ITEM 7.01. Regulation FD.

This excerpt taken from the EYE 8-K filed Jan 27, 2009.

ITEM 7.01.  Regulation FD.

 

On January 27, 2009, Advanced Medical Optics, Inc., a Delaware corporation (“AMO”), announced that it commenced a cash tender offer for its outstanding 7½% Senior Subordinated Notes due 2017 (the “Notes”) and a related consent solicitation to amend the indenture governing the Notes. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein. The tender offer is being conducted in connection with, and is conditioned on, among other things, the consummation of the pending acquisition of AMO by Abbott Laboratories.

 

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki